SeaStar Medical (NASDAQ:ICU) Announces Quarterly Earnings Results

SeaStar Medical (NASDAQ:ICU) issued its earnings results on Thursday. The company reported ($0.90) EPS for the quarter, missing the consensus estimate of ($0.89) by ($0.01), Zacks reports. The business had revenue of $0.07 million for the quarter, compared to the consensus estimate of $0.15 million.

SeaStar Medical Trading Down 9.5 %

Shares of SeaStar Medical stock opened at $2.20 on Friday. The company has a 50-day moving average of $1.87 and a two-hundred day moving average of $2.65. SeaStar Medical has a 12-month low of $1.50 and a 12-month high of $20.70. The stock has a market cap of $14.24 million, a PE ratio of -0.19 and a beta of -0.97.

About SeaStar Medical

SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome.